Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

IMV Inc IMVIF

IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

Bullboard Posts
Comment by PoorOpinionon Nov 20, 2018 6:13pm
115 Views
Post# 29002079

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:DPX-Survivac as Monotherapy For Recurring Ovarian Cancer

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:DPX-Survivac as Monotherapy For Recurring Ovarian Cancer
alphaseeking001 wrote: Yikes... hoping it won't take that long to get breakthrough status...!  Super excited about today's announcements BTW.  They had already suspected that it was DPX-Survivac that was giving all the beneficial clinical effects and not Incyte's drug.  This is much better for us.


If you want to get more positively excited about that drugs progress then Pharmacyclics seems to be the Small Cap behind that drug, its stock went from $5 to $120 over that time period and ended being sold for many billions. But dont say I said any of that, hate to fuel dreams!
Bullboard Posts